Skip to main content
SpringerLink
Log in

Rationale for Once-Daily Therapy in Asthma

Compliance Issues

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

Compliance in asthma is known to be poor. Once-daily treatment provides an additional therapeutic option for the clinician whose treatment aims include maximising treatment satisfaction and compliance. Once-daily treatment is preferred by some but not all patients and may lead to greater compliance in patients who are concerned about the effect of corticosteroids on their health. When switching to once-daily treatment, patients should be given a choice as to the time of treatment to minimise the impact of forgetting a dose.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Marinker M. Compliance is not all. BMJ 1998; 316: 150–1

    Article  PubMed  CAS  Google Scholar 

  2. Spilker B. Quality of life assessments in clinical trials. New York: Raven Press, 1990

    Google Scholar 

  3. Juniper EF, Guyatt GH, Epstein RS, et al. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47: 76–83

    Article  PubMed  CAS  Google Scholar 

  4. Hyland ME, Finnis S, Irvine SH. A scale for assessing quality of life in adult asthma sufferers. J Psychosom Res 1991; 35: 99–110

    Article  PubMed  CAS  Google Scholar 

  5. Jones PW, Quirk FH, Baveystock CM. The St George’s Respiratory Questionnaire. Respir Med 1991; 85 Suppl. B: 25–31

    Article  PubMed  Google Scholar 

  6. Hyland ME, Ley A, Fisher DW, et al. Measurement of psychological distress in asthma and asthma management programmes. Br J Clin Psychol 1995; 34: 601–11

    Article  PubMed  Google Scholar 

  7. Chmelik F, Doughty A. Objective measurements of compliance in asthma treatment. Ann Allergy 1994; 73: 527–32

    PubMed  CAS  Google Scholar 

  8. Mawhinney H, Spector SL, Kinsman RA, et al. Compliance in clinical trials of two nonbronchodilator, antiasthma medications. Ann Allergy 1991; 66: 294–8

    PubMed  CAS  Google Scholar 

  9. Spector SL, Kinsman R, Mawhinney H, et al. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. J Allergy Clin Immunol 1986; 77: 65–70

    Article  PubMed  CAS  Google Scholar 

  10. Mawhinney H, Spector SL, Heitjan D, et al. As-needed medication use in asthma usage patterns and patient characteristics. J Asthma 1993; 30: 61–71

    Article  PubMed  CAS  Google Scholar 

  11. Bosley CM, Parry DT, Cochrane GM. Patient compliance with inhaled medication — does combining beta-agonists with corticosteroids improve compliance? EurRespir J 1994; 7: 504–9

    CAS  Google Scholar 

  12. Osman LM, Russell IT, Friend JA, et al. Predicting patient attitudes to asthma medication. Thorax 1993; 48: 827–30

    Article  PubMed  CAS  Google Scholar 

  13. Van Zuuren FJ, Dooper R. Coping style and self-reported health promotion and disease detection behaviour. Br J Health Psychol 1999; 4: 81–9

    Article  Google Scholar 

  14. Heuck C, Wolthers OD, Kollerup G, et al. Adverse effects of inhaled budesonide (800 μg) on growth and collagen turnover in children with asthma: a double-blind comparison of once-daily versus twice-daily administration. J Pediatr 1998; 133: 608–12

    Article  PubMed  CAS  Google Scholar 

  15. Edsbäcker S. Pharmacological factors that influence the choice of inhaled corticosteroids. Drugs 1999; 58 Suppl. 4: 7–16

    Article  PubMed  Google Scholar 

  16. Baddeley A. Human memory: theory and practice. London: Earlbaum, 1990

    Google Scholar 

  17. Raphael KG, Cloitre M, Dohrenwend BP. Problems of recall and misclassification with checklist methods of measuring stressful life events. Health Psychol 1991; 10: 62–74

    Article  PubMed  CAS  Google Scholar 

  18. Venables TL, Addlestone MB, Smithers AJ, et al. A comparison of the efficacy and patient acceptability of once daily budesonide via Turbuhaler and twice daily fluticasone propionate via a disc-inhaler at an equal dose of 400mcg in adult asthmatics. Br J Clin Res 1996; 7: 15–32

    Google Scholar 

  19. Möller C. Once-daily inhaled corticosteroids in children with asthma: dry powder inhalers. Drugs 1999; 58 Suppl. 4: 35–41

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychology, University of Plymouth, Plymouth, PL4 8AA, England

    Michael E. Hyland

Authors
  1. Michael E. Hyland
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hyland, M.E. Rationale for Once-Daily Therapy in Asthma. Drugs 58 (Suppl 4), 1–6 (1999). https://doi.org/10.2165/00003495-199958004-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199958004-00001

Keywords

Search

Navigation